EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes

Răzvan Alexandru Marinescu, Daniela Marinescu, Lidia Boldeanu iD, Ana-Maria Ciurea iD, Marius Bică, Ștefan Pătrașcu, Victor Dan Eugen Strâmbu, Petru Adrian Radu, Petrica Popa iD, Mohamed-Zakaria Assani iD, Mihail Virgil Boldeanu iD, Valeriu Șurlin iD

Diagnostics · 09.03.2026 · 16 (5) · 810

DOI: 10.3390/diagnostics16050810 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Diagnostics, online erschienen am 09.03.2026. Verfasst von Răzvan Alexandru Marinescu und 11 weiteren Autor:innen. Beteiligte Einrichtung: Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania. Die Arbeit nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Medicine and Pharmacy of Craiova, Romania.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Type 2 diabetes mellitus (T2DM) and atherogenic dyslipidemia have been implicated in colorectal cancer (CRC) development, but their prognostic relevance after cancer diagnosis remains unclear. This study aimed to evaluate the association between T2DM, lipid-derived atherogenic indices, and survival outcomes in patients with CRC.

Methods

We conducted a retrospective cohort study including 240 CRC patients, of whom 60 had coexisting T2DM. Overall survival (OS) and disease-free survival (DFS) were analyzed using the Kaplan–Meier (KM) method and log-rank tests. In the absence of recurrence-specific data, DFS was defined as time to death or last follow-up. Lipid-related indices, including the atherogenic index of plasma (AIP), atherogenic coefficient (AC), remnant cholesterol (RC), non-high-density lipoprotein cholesterol (non-HDL-C), triglyceride–glucose (TyG) index, and triglyceride-to-HDL cholesterol ratio (TG/HDL-C), were evaluated by tertiles in KM analyses. Multivariable Cox proportional hazards models were constructed to assess the independent prognostic value of AIP, AC, and RC (entered separately as a continuous variable standardized to 1 standard deviation), adjusted for age, sex, adjuvant chemotherapy, radiotherapy, and T2DM status. Sensitivity analyses were performed in stage III–IV patients.

Results

During follow-up, 28 deaths occurred. OS did not differ significantly between CRC patients and those with CRC coexisting with T2DM (log-rank p-values = 0.220). DFS analyses showed no significant differences across tertiles of any lipid-related index (all log-rank p-values > 0.05), with overlapping survival curves and no consistent dose–response patterns. In adjusted Cox models, AIP (hazard ratio [HR] per 1 SD = 0.71, 95% CI 0.48–1.06), AC (HR = 0.72, 95% CI 0.44–1.20), and RC (HR = 0.66, 95% CI 0.39–1.12) were not independently associated with DFS. Results were consistent in advanced-stage disease (stage III–IV).

Conclusions

In this cohort of patients with CRC, neither T2DM nor lipid-derived indices reflecting atherogenic dyslipidemia and insulin resistance were independently associated with OS or DFS. These findings help refine the clinical interpretation of lipid-derived biomarkers in CRC, suggesting limited prognostic utility beyond established oncologic factors.

Schlagwörter

Stichwörter der Autor:innen

AIPTyGatherogenic indicescolorectal cancerprognosisremnant cholesterolsurvivaltriglyceride-to-HDL ratiotype 2 diabetes mellitus

Autor:innen und Institutionen

  • Doctoral School, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Surgery, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Microbiology, Faculty of Medicine, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Oncology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.
  • Department of Surgery, University of Medicine and Pharmacy "Carol Davila", 020021 Bucharest, Romania.
  • Department of Gastroenterology, University of Medicine and Pharmacy of Craiova, 200349 Craiova, Romania.

ORCID-Profile: Lidia Boldeanu, Ana-Maria Ciurea, Petrica Popa, Mohamed-Zakaria Assani, Mihail Virgil Boldeanu, Valeriu Șurlin

Förderung

  • University of Medicine and Pharmacy of Craiova, Romania

Zitieren

APA

Marinescu, R. A., Marinescu, D., Boldeanu, L., Ciurea, A. M., Bică, M., Pătrașcu, Ș., Strâmbu, V. D. E., Radu, P. A., Popa, P., Assani, M. Z., Boldeanu, M. V., & Șurlin, V. (2026). Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes. Diagnostics, 16(5), 810. https://doi.org/10.3390/diagnostics16050810

Vancouver

Marinescu RA, Marinescu D, Boldeanu L, Ciurea AM, Bică M, Pătrașcu Ș, et al. Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes. Diagnostics. 2026;16(5):810. doi:10.3390/diagnostics16050810

BibTeX
@article{Marinescu2026,
  author = {Marinescu, Răzvan Alexandru and Marinescu, Daniela and Boldeanu, Lidia and Ciurea, Ana-Maria and Bică, Marius and Pătrașcu, Ștefan and Strâmbu, Victor Dan Eugen and Radu, Petru Adrian and Popa, Petrica and Assani, Mohamed-Zakaria and Boldeanu, Mihail Virgil and Șurlin, Valeriu},
  title = {Atherogenic Lipid Indices in Colorectal Cancer: Metabolic Associations and Survival Outcomes},
  journal = {Diagnostics},
  year = {2026},
  volume = {16},
  number = {5},
  pages = {810},
  doi = {10.3390/diagnostics16050810}
}
Kostenlos starten →